$6.75 Billion is the total value of Eventide Asset Management's 156 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 31.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EXAS | EXACT SCIENCES CORP | $229,297,000 | -0.5% | 1,740,000 | 0.0% | 3.40% | -3.9% | |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $218,922,000 | -23.0% | 1,698,648 | -0.3% | 3.24% | -25.6% |
| FIVN | Buy | FIVE9 INC | $184,273,000 | -9.6% | 1,178,742 | +0.8% | 2.73% | -12.7% |
| TTD | Buy | THE TRADE DESK INC | $178,767,000 | -17.9% | 274,325 | +1.0% | 2.65% | -20.6% |
| CRWD | Sell | CROWDSTRIKE HLDGS INCcl a | $162,668,000 | -23.4% | 891,285 | -11.1% | 2.41% | -26.0% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $137,725,000 | -9.9% | 2,015,000 | +13.0% | 2.04% | -12.9% |
| TWLO | Buy | TWILIO INCcl a | $133,609,000 | +0.9% | 392,090 | +0.3% | 1.98% | -2.5% |
| DT | Sell | DYNATRACE INC | $129,177,000 | +10.0% | 2,677,808 | -1.3% | 1.91% | +6.3% |
| ROP | Buy | ROPER TECHNOLOGIES INC | $125,318,000 | -5.1% | 310,700 | +1.5% | 1.86% | -8.3% |
| LRCX | Buy | LAM RESEARCH CORP | $121,694,000 | +26.3% | 204,446 | +0.2% | 1.80% | +22.0% |
| MTD | METTLER TOLEDO INTERNATIONAL | $119,036,000 | +1.4% | 103,000 | 0.0% | 1.76% | -2.0% | |
| IDXX | IDEXX LABS INC | $117,434,000 | -2.1% | 240,000 | 0.0% | 1.74% | -5.4% | |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $116,753,000 | +27.5% | 971,077 | +7.8% | 1.73% | +23.2% |
| FVRR | Buy | FIVERR INTL LTD | $115,445,000 | +12.3% | 531,562 | +0.9% | 1.71% | +8.5% |
| PRAX | PRAXIS PRECISION MEDICINES, INC | $109,410,000 | -40.5% | 3,513,081 | 0.0% | 1.62% | -42.5% | |
| HUBS | HUBSPOT INC | $107,642,000 | +14.6% | 236,987 | 0.0% | 1.60% | +10.7% | |
| ASML | ASML HOLDING N V | $106,186,000 | +26.6% | 172,000 | 0.0% | 1.57% | +22.4% | |
| TT | Buy | TRANE TECHNOLOGIES PLC | $102,780,000 | +16.6% | 620,800 | +2.3% | 1.52% | +12.7% |
| LOW | Sell | LOWES COS INC | $98,779,000 | +16.9% | 519,400 | -1.3% | 1.46% | +13.1% |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $98,322,000 | +9.8% | 1,349,100 | +1.0% | 1.46% | +6.1% |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $97,220,000 | +50.8% | 2,471,892 | -12.9% | 1.44% | +45.7% |
| ZI | Buy | ZOOMINFO TECHNOLOGIES INC | $95,225,000 | +4.0% | 1,947,351 | +2.6% | 1.41% | +0.5% |
| DHI | Buy | D R HORTON INC | $94,725,000 | +80.9% | 1,062,893 | +39.9% | 1.40% | +74.8% |
| ODFL | Buy | OLD DOMINION FREIGHT LINE IN | $91,136,000 | +28.3% | 379,085 | +4.1% | 1.35% | +24.1% |
| WCN | WASTE CONNECTIONS INC | $86,816,000 | +5.3% | 804,000 | 0.0% | 1.29% | +1.7% | |
| POOL | Sell | POOL CORP | $86,379,000 | -7.9% | 250,200 | -0.6% | 1.28% | -11.0% |
| CTAS | Buy | CINTAS CORP | $83,348,000 | +31.7% | 244,200 | +36.4% | 1.24% | +27.3% |
| Buy | TRILLIUM THERAPEUTICS INC | $82,258,000 | +17.0% | 7,659,000 | +60.2% | 1.22% | +13.0% | |
| TREX | TREX CO INC | $80,738,000 | +9.3% | 882,000 | 0.0% | 1.20% | +5.7% | |
| W | Sell | WAYFAIR INCcl a | $77,564,000 | -14.6% | 246,432 | -38.7% | 1.15% | -17.5% |
| GNRC | Buy | GENERAC HLDGS INC | $75,052,000 | +130.8% | 229,200 | +60.3% | 1.11% | +122.8% |
| VRSK | Buy | VERISK ANALYTICS INC | $75,058,000 | -13.8% | 424,800 | +1.3% | 1.11% | -16.7% |
| MGA | Buy | MAGNA INTL INC | $74,658,000 | +31.3% | 848,000 | +5.6% | 1.11% | +26.8% |
| APTV | APTIV PLC | $74,052,000 | +5.8% | 537,000 | 0.0% | 1.10% | +2.2% | |
| EPIX | Buy | ESSA PHARMA INC | $69,870,000 | +164.0% | 2,405,169 | +3.0% | 1.04% | +154.9% |
| ENTG | Buy | ENTEGRIS INC | $68,880,000 | +823.3% | 616,099 | +693.6% | 1.02% | +795.6% |
| RNG | Buy | RINGCENTRAL INCcl a | $65,864,000 | -19.5% | 221,108 | +2.4% | 0.98% | -22.2% |
| VITL | Buy | VITAL FARMS INC | $65,700,000 | +26.4% | 3,008,232 | +46.5% | 0.97% | +22.2% |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $65,568,000 | – | 3,714,032 | +100.0% | 0.97% | – |
| ARGX | Buy | ARGENX SEsponsored adr | $58,933,000 | +25.2% | 214,000 | +33.8% | 0.87% | +20.9% |
| SPT | Sell | SPROUT SOCIAL INC | $58,391,000 | +26.7% | 1,010,920 | -0.4% | 0.86% | +22.3% |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $57,543,000 | +18.3% | 2,427,976 | 0.0% | 0.85% | +14.3% | |
| ANNX | ANNEXON INC | $54,697,000 | +11.2% | 2,004,616 | 0.0% | 0.81% | +7.6% | |
| CCI | Buy | CROWN CASTLE INTL CORP NEW | $54,049,000 | +22.4% | 314,000 | +13.2% | 0.80% | +18.3% |
| STRO | SUTRO BIOPHARMA INC | $53,963,000 | +4.8% | 2,370,975 | 0.0% | 0.80% | +1.4% | |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $53,593,000 | +1805.2% | 453,100 | +1656.2% | 0.79% | +1746.5% |
| BEP | BROOKFIELD RENEWABLE PARTNERpartnership unit | $52,654,000 | -1.3% | 1,236,000 | 0.0% | 0.78% | -4.6% | |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $51,959,000 | -67.3% | 697,156 | -25.2% | 0.77% | -68.4% |
| YETI | YETI HLDGS INC | $49,825,000 | +5.5% | 690,000 | 0.0% | 0.74% | +1.9% | |
| CGEM | New | CULLINAN ONCOLOGY INC | $49,025,000 | – | 1,212,555 | +100.0% | 0.73% | – |
| PANW | Buy | PALO ALTO NETWORKS INC | $48,063,000 | -8.9% | 149,237 | +0.5% | 0.71% | -12.0% |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $47,768,000 | -32.8% | 505,000 | -13.4% | 0.71% | -35.0% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $46,097,000 | +36.2% | 474,000 | +34.3% | 0.68% | +31.6% |
| BEPC | Buy | BROOKFIELD RENEWABLE CORPcl a sub vtg | $45,787,000 | +68.1% | 978,357 | +109.3% | 0.68% | +62.4% |
| KURA | Buy | KURA ONCOLOGY INC | $45,729,000 | +32.1% | 1,617,573 | +52.6% | 0.68% | +27.7% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $45,100,000 | +4.2% | 2,016,993 | +3.6% | 0.67% | +0.6% |
| BPMC | BLUEPRINT MEDICINES CORP | $44,920,000 | -13.3% | 462,000 | 0.0% | 0.67% | -16.2% | |
| ZYME | New | ZYMEWORKS INC | $44,147,000 | – | 1,397,954 | +100.0% | 0.65% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $43,871,000 | – | 712,197 | +100.0% | 0.65% | – |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $42,486,000 | +32.0% | 2,062,433 | +12.3% | 0.63% | +27.5% |
| IMVT | Buy | IMMUNOVANT INC | $39,667,000 | -7.9% | 2,473,000 | +165.3% | 0.59% | -10.9% |
| DDOG | Buy | DATADOG INC | $39,245,000 | -14.7% | 470,903 | +0.7% | 0.58% | -17.6% |
| HASI | Sell | HANNON ARMSTRONG SUST INFR C | $39,281,000 | -25.6% | 700,200 | -15.9% | 0.58% | -28.1% |
| NRIX | Buy | NURIX THERAPEUTICS INC | $37,308,000 | +8.1% | 1,200,000 | +14.3% | 0.55% | +4.5% |
| NOVT | NOVANTA INC | $36,929,000 | +11.6% | 280,000 | 0.0% | 0.55% | +7.7% | |
| CWEN | Buy | CLEARWAY ENERGY INCcl c | $36,679,000 | -7.9% | 1,303,400 | +4.5% | 0.54% | -11.0% |
| MAX | Buy | MEDIAALPHA INCcl a | $36,654,000 | +1422.8% | 1,034,559 | +1579.2% | 0.54% | +1367.6% |
| ALLK | ALLAKOS INC | $36,385,000 | -18.0% | 317,000 | 0.0% | 0.54% | -20.9% | |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $36,100,000 | -16.5% | 832,000 | 0.0% | 0.54% | -19.3% | |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $35,272,000 | +10.6% | 1,373,000 | -18.3% | 0.52% | +7.0% |
| VCYT | Sell | VERACYTE INC | $34,991,000 | -23.1% | 651,000 | -30.0% | 0.52% | -25.6% |
| ETNB | Buy | 89BIO INC | $30,039,000 | +41.8% | 1,268,539 | +46.0% | 0.44% | +36.9% |
| CGNX | COGNEX CORP | $29,793,000 | +3.4% | 359,000 | 0.0% | 0.44% | 0.0% | |
| FRLN | FREELINE THERAPEUTICS HLDGSsponsored ads | $29,818,000 | -32.6% | 2,485,656 | 0.0% | 0.44% | -34.9% | |
| LII | LENNOX INTL INC | $29,601,000 | +13.7% | 95,000 | 0.0% | 0.44% | +10.0% | |
| CCXI | Buy | CHEMOCENTRYX INC | $28,694,000 | +19.7% | 560,000 | +44.7% | 0.42% | +15.8% |
| SMAR | SMARTSHEET INC | $27,933,000 | -7.8% | 437,000 | 0.0% | 0.41% | -10.8% | |
| XPO | XPO LOGISTICS INC | $27,126,000 | +3.4% | 220,000 | 0.0% | 0.40% | 0.0% | |
| SWKS | Sell | SKYWORKS SOLUTIONS INC | $27,072,000 | -1.9% | 147,547 | -18.3% | 0.40% | -5.2% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $26,671,000 | +68.3% | 1,490,000 | +44.6% | 0.40% | +62.6% |
| KROS | Buy | KEROS THERAPEUTICS INC | $26,307,000 | +7.8% | 427,414 | +23.5% | 0.39% | +4.3% |
| MPWR | Buy | MONOLITHIC PWR SYS INC | $26,194,000 | -1.8% | 74,159 | +1.8% | 0.39% | -5.1% |
| ROL | ROLLINS INC | $25,041,000 | -11.9% | 727,500 | 0.0% | 0.37% | -14.9% | |
| OKTA | OKTA INCcl a | $23,806,000 | -13.3% | 108,000 | 0.0% | 0.35% | -16.2% | |
| MDB | MONGODB INCcl a | $23,796,000 | -25.5% | 88,980 | 0.0% | 0.35% | -28.0% | |
| KALA | KALA PHARMACEUTICALS INC | $23,253,000 | -0.6% | 3,450,000 | 0.0% | 0.34% | -3.9% | |
| RGEN | REPLIGEN CORP | $23,135,000 | +1.5% | 119,000 | 0.0% | 0.34% | -2.0% | |
| PHAT | PHATHOM PHARMACEUTICALS INC | $22,536,000 | +13.1% | 600,000 | 0.0% | 0.33% | +9.2% | |
| ADCT | Sell | ADC THERAPEUTICS SA | $22,329,000 | -35.1% | 914,739 | -14.9% | 0.33% | -37.3% |
| MRTX | MIRATI THERAPEUTICS INC | $22,178,000 | -22.0% | 129,471 | 0.0% | 0.33% | -24.5% | |
| XNCR | XENCOR INC | $21,788,000 | -1.3% | 506,000 | 0.0% | 0.32% | -4.7% | |
| SHC | SOTERA HEALTH CO | $21,715,000 | -9.0% | 870,000 | 0.0% | 0.32% | -12.0% | |
| BYND | New | BEYOND MEAT INC | $19,855,000 | – | 152,593 | +100.0% | 0.29% | – |
| XLRN | ACCELERON PHARMA INC | $19,379,000 | +6.0% | 142,900 | 0.0% | 0.29% | +2.5% | |
| BFLY | New | BUTTERFLY NETWORK INC | $18,816,000 | – | 1,118,000 | +100.0% | 0.28% | – |
| ISRG | INTUITIVE SURGICAL INC | $18,474,000 | -9.7% | 25,000 | 0.0% | 0.27% | -12.7% | |
| FRC | Buy | FIRST REP BK SAN FRANCISCO C | $16,542,000 | +75.1% | 99,200 | +54.3% | 0.24% | +69.0% |
| CRDF | New | CARDIFF ONCOLOGY INC | $16,515,000 | – | 1,783,488 | +100.0% | 0.24% | – |
| MASS | 908 DEVICES INC | $16,164,000 | -14.8% | 333,283 | 0.0% | 0.24% | -17.5% | |
| SBTX | Buy | SILVERBACK THERAPEUTICS INC | $16,203,000 | +2.4% | 371,384 | +8.8% | 0.24% | -1.2% |
| CIEN | Buy | CIENA CORP | $15,769,000 | +11.7% | 288,175 | +7.9% | 0.23% | +8.3% |
| A | Buy | AGILENT TECHNOLOGIES INC | $15,727,000 | +43.5% | 123,700 | +33.7% | 0.23% | +38.7% |
| LW | LAMB WESTON HLDGS INC | $15,728,000 | -1.6% | 203,000 | 0.0% | 0.23% | -4.9% | |
| FHN | Buy | FIRST HORIZON CORPORATION | $14,691,000 | +66.0% | 868,800 | +25.2% | 0.22% | +60.3% |
| PHVS | New | PHARVARIS N V | $14,030,000 | – | 500,000 | +100.0% | 0.21% | – |
| APTOSE BIOSCIENCES INC | $13,737,000 | +36.4% | 2,299,000 | 0.0% | 0.20% | +32.5% | ||
| SHLS | New | SHOALS TECHNOLOGIES GROUP INcl a added | $13,654,000 | – | 392,556 | +100.0% | 0.20% | – |
| PLD | Buy | PROLOGIS INC. | $13,043,000 | +43.7% | 123,044 | +35.1% | 0.19% | +38.8% |
| STE | Buy | STERIS PLC | $12,876,000 | +114.6% | 67,600 | +113.6% | 0.19% | +107.6% |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $12,302,000 | – | 411,838 | +100.0% | 0.18% | – |
| SNV | New | SYNOVUS FINL CORP | $12,165,000 | – | 265,900 | +100.0% | 0.18% | – |
| DSGN | New | DESIGN THERAPEUTICS INC | $11,960,000 | – | 400,000 | +100.0% | 0.18% | – |
| KLAC | Buy | KLA CORP | $11,828,000 | +79.2% | 35,798 | +40.4% | 0.18% | +73.3% |
| PNR | Buy | PENTAIR PLC | $11,137,000 | +109.6% | 178,700 | +78.5% | 0.16% | +103.7% |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $10,628,000 | – | 322,944 | +100.0% | 0.16% | – |
| ORIC | ORIC PHARMACEUTICALS INC | $10,535,000 | -27.6% | 430,000 | 0.0% | 0.16% | -30.0% | |
| SGFY | New | SIGNIFY HEALTH INC | $10,456,000 | – | 357,360 | +100.0% | 0.16% | – |
| CHMA | CHIASMA INC | $9,391,000 | -28.0% | 3,000,326 | 0.0% | 0.14% | -30.5% | |
| SBNY | Buy | SIGNATURE BK NEW YORK N Y | $8,411,000 | +140.0% | 37,200 | +43.6% | 0.12% | +131.5% |
| IEX | Buy | IDEX CORP | $7,891,000 | +126.0% | 37,700 | +115.1% | 0.12% | +116.7% |
| Buy | PALO ALTO NETWORKS INCnote 0.750% 7/0 | $7,852,000 | +28.2% | 5,928,000 | +36.8% | 0.12% | +23.4% | |
| SNPS | Buy | SYNOPSYS INC | $6,927,000 | +54.4% | 27,957 | +61.5% | 0.10% | +49.3% |
| ALXO | New | ALX ONCOLOGY HLDGS INC | $6,637,000 | – | 90,000 | +100.0% | 0.10% | – |
| VFC | Buy | V F CORP | $6,521,000 | +223.5% | 81,600 | +245.8% | 0.10% | +212.9% |
| FENC | Sell | FENNEC PHARMACEUTICALS INC | $6,458,000 | -22.6% | 1,040,000 | -7.1% | 0.10% | -25.0% |
| AWK | Buy | AMERICAN WTR WKS CO INC NEW | $6,462,000 | +45.7% | 43,100 | +49.1% | 0.10% | +41.2% |
| SBAC | Buy | SBA COMMUNICATIONS CORP NEWcl a | $6,319,000 | +28.2% | 22,766 | +30.3% | 0.09% | +23.7% |
| ARE | Buy | ALEXANDRIA REAL ESTATE EQ IN | $6,293,000 | +9.3% | 38,300 | +18.6% | 0.09% | +5.7% |
| ELS | New | EQUITY LIFESTYLE PPTYS INC | $6,065,000 | – | 95,300 | +100.0% | 0.09% | – |
| SLDB | New | SOLID BIOSCIENCES INC | $5,983,000 | – | 1,081,868 | +100.0% | 0.09% | – |
| SYY | Buy | SYSCO CORP | $5,858,000 | +43.4% | 74,400 | +35.3% | 0.09% | +38.1% |
| GRMN | Buy | GARMIN LTD | $5,643,000 | +125.6% | 42,800 | +104.8% | 0.08% | +121.1% |
| MSCI | Buy | MSCI INC | $4,696,000 | +47.1% | 11,200 | +56.6% | 0.07% | +42.9% |
| ZTS | Buy | ZOETIS INCcl a | $4,504,000 | +22.6% | 28,600 | +28.8% | 0.07% | +19.6% |
| EXACT SCIENCES CORPnote 1.000% 1/1 | $4,525,000 | -1.2% | 2,411,000 | 0.0% | 0.07% | -4.3% | ||
| New | RINGCENTRAL INCnote 3/0 | $4,336,000 | – | 3,940,000 | +100.0% | 0.06% | – | |
| NDAQ | Buy | NASDAQ INC | $3,952,000 | +58.3% | 26,800 | +42.6% | 0.06% | +55.3% |
| FOUR | Buy | SHIFT4 PMTS INCcl a | $3,786,000 | +57.6% | 46,160 | +44.9% | 0.06% | +51.4% |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $3,685,000 | -34.7% | 241,140 | -39.7% | 0.06% | -36.8% |
| OLK | New | OLINK HLDG ABsponsored ads added | $3,636,000 | – | 101,000 | +100.0% | 0.05% | – |
| ZBH | ZIMMER BIOMET HOLDINGS INC | $3,237,000 | +3.9% | 20,220 | 0.0% | 0.05% | 0.0% | |
| JKHY | Sell | HENRY JACK & ASSOC INC | $2,974,000 | -54.3% | 19,600 | -51.2% | 0.04% | -56.0% |
| New | EXACT SCIENCES CORPnote 0.375% 3/0 | $2,720,000 | – | 2,100,000 | +100.0% | 0.04% | – | |
| LSCC | Buy | LATTICE SEMICONDUCTOR CORP | $2,631,000 | +64.3% | 58,447 | +67.3% | 0.04% | +56.0% |
| NXPI | Sell | NXP SEMICONDUCTORS N V | $2,396,000 | -17.2% | 11,900 | -34.6% | 0.04% | -18.2% |
| AMD | Buy | ADVANCED MICRO DEVICES INC | $2,377,000 | +26.3% | 30,285 | +47.6% | 0.04% | +20.7% |
| DBTX | New | DECIBEL THERAPEUTICS INC | $2,272,000 | – | 200,000 | +100.0% | 0.03% | – |
| SHW | Sell | SHERWIN WILLIAMS CO | $2,066,000 | -33.1% | 2,800 | -33.3% | 0.03% | -34.0% |
| OM | Buy | OUTSET MED INC | $1,971,000 | +32.2% | 36,237 | +38.1% | 0.03% | +26.1% |
| SLAB | Buy | SILICON LABORATORIES INC | $1,754,000 | +49.8% | 12,437 | +35.2% | 0.03% | +44.4% |
| Sell | NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,300,000 | -63.6% | 960,000 | -62.6% | 0.02% | -65.5% | |
| ETTX | Sell | ENTASIS THERAPEUTICS HLDGS I | $1,264,000 | -38.8% | 590,602 | -32.9% | 0.02% | -40.6% |
| TTD | New | THE TRADE DESK INCcall | $1,125,000 | – | 1,500 | +100.0% | 0.02% | – |
| DOCU | DOCUSIGN INC | $976,000 | -8.9% | 4,819 | 0.0% | 0.01% | -12.5% | |
| PAYC | New | PAYCOM SOFTWARE INC | $925,000 | – | 2,500 | +100.0% | 0.01% | – |
| ONTF | New | ON24 INC | $654,000 | – | 13,478 | +100.0% | 0.01% | – |
| APPN | Exit | APPIAN CORPput | $0 | – | -3,000 | -100.0% | -0.01% | – |
| AMWL | Exit | AMERICAN WELL CORPput | $0 | – | -21,000 | -100.0% | -0.01% | – |
| NEWR | Exit | NEW RELIC INCput | $0 | – | -12,000 | -100.0% | -0.01% | – |
| LMND | Exit | LEMONADE INCput | $0 | – | -17,000 | -100.0% | -0.01% | – |
| IMTXW | Exit | IMMATICS N.V*w exp 07/01/202 | $0 | – | -400,000 | -100.0% | -0.02% | – |
| DPZ | Exit | DOMINOS PIZZA INC | $0 | – | -3,110 | -100.0% | -0.02% | – |
| EQIX | Exit | EQUINIX INC | $0 | – | -2,520 | -100.0% | -0.03% | – |
| FATE | Exit | FATE THERAPEUTICS INCput | $0 | – | -18,900 | -100.0% | -0.03% | – |
| AMWL | Exit | AMERICAN WELL CORPcl a | $0 | – | -110,091 | -100.0% | -0.04% | – |
| KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -175,000 | -100.0% | -0.11% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -0.12% | – |
| IMTX | Exit | IMMATICS N.V | $0 | – | -800,000 | -100.0% | -0.13% | – |
| ITT | Exit | ITT INC | $0 | – | -117,800 | -100.0% | -0.14% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -112,000 | -100.0% | -0.17% | – |
| ABCL | Exit | ABCELLERA BIOLOGICS INC | $0 | – | -300,000 | -100.0% | -0.18% | – |
| MKC | Exit | MCCORMICK & CO INC | $0 | – | -128,840 | -100.0% | -0.19% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -243,000 | -100.0% | -0.21% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -30,900 | -100.0% | -0.23% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -102,500 | -100.0% | -0.28% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -1,305,307 | -100.0% | -0.28% | – |
| LGVW | Exit | LONGVIEW ACQUISITION CORP | $0 | – | -1,118,000 | -100.0% | -0.34% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -206,000 | -100.0% | -0.36% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INCput | $0 | – | -551,400 | -100.0% | -0.46% | – |
| EDIT | Exit | EDITAS MEDICINE INCput | $0 | – | -583,900 | -100.0% | -0.58% | – |
| EIDX | Exit | EIDOS THERAPEUTICS INC | $0 | – | -317,417 | -100.0% | -0.64% | – |
| ECL | Exit | ECOLAB INC | $0 | – | -230,000 | -100.0% | -0.76% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 43 | Q2 2024 | 3.2% |
| PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
| ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
| REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
| VERACYTE INC | 41 | Q2 2024 | 1.5% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
| COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
| BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
| Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
| Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
| Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
| Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
| Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-13 |
| SC 13G/A | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.